Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head/Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04247282
What this trial is testing

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Who this might be right for
Head and Neck CancerHead and Neck Neoplasms
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)Study completedNCT01228565
What this trial is testing

Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®

Who this might be right for
Head and Neck Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 76
Not applicableUnknownNCT04810936
What this trial is testing

Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy

Who this might be right for
MalnutritionNasopharyngeal Carcinoma
Guangdong Provincial People's Hospital 272
Large-scale testing (Phase 3)UnknownNCT01402180
What this trial is testing

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT00370890
What this trial is testing

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Who this might be right for
Nasopharyngeal Cancer
Chinese University of Hong Kong 104
Not applicableUnknownNCT04419324
What this trial is testing

To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Chinese University of Hong Kong 40
Testing effectiveness (Phase 2)UnknownNCT06231680
What this trial is testing

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Who this might be right for
Lung Cancer, Nonsmall CellEsophageal Carcinoma
Henan Cancer Hospital 132
Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing

Oral Rigosertib for Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Early research (Phase 1)Study completedNCT01379339
What this trial is testing

Cabazitaxel - PF Induction Chemotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Krzysztof Misiukiewicz 40
Not applicableStudy completedNCT01487057
What this trial is testing

Lipid Metabolic Status in Thyroid Carcinoma

Who this might be right for
Thyroid CarcinomaDyslipidemiasRisk Reduction Behavior+1 more
Prof. Dr. I. Chiricuta Institute of Oncology 52
Testing effectiveness (Phase 2)WithdrawnNCT02649530
What this trial is testing

A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma, Head And Neck
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00484601
What this trial is testing

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Who this might be right for
Refractory Nasopharyngeal Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Looking for participantsNCT07457528
What this trial is testing

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 46
Not applicableLooking for participantsNCT07508319
What this trial is testing

Role of the Immune System in Preventing Laryngeal Cancer

Who this might be right for
Head & Neck Cancer
European Institute of Oncology 3
Next Page